Departamento
Farmacología
Publicaciones (35) Publicaciones en las que ha participado algún/a investigador/a
2012
-
A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia
Journal of Psychiatric Research, Vol. 46, Núm. 11, pp. 1464-1474
-
Altered pallido-pallidal synaptic transmission leads to aberrant firing of globus pallidus neurons in a rat model of Parkinson's disease
Journal of Physiology, Vol. 590, Núm. 22, pp. 5861-5875
-
Cellular neurochemical characterization and subcellular localization of phospholipase C β1 in rat brain
Neuroscience, Vol. 222, pp. 239-268
-
Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain
Neuroscience, Vol. 215, pp. 17-30
-
Differential regulation of RGS proteins in the prefrontal cortex of short- and long-term human opiate abusers
Neuropharmacology, Vol. 62, Núm. 2, pp. 1044-1051
-
EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5
FASEB Journal, Vol. 26, Núm. 12, pp. 4841-4854
-
Effect of synthetic cannabinoid CB1 agonist (WIN 55212-2) and antagonist (AM 251) on intraocular pressure in rats
Glaucoma: Etiology, Pathogenesis and Treatments (Nova Science Publishers, Inc.), pp. 147-156
-
Endocannabinoid modulation of dopaminergic motor circuits
Frontiers in Pharmacology, Vol. 3 JUN
-
Endomorphin-2: A biased agonist at the μ-opioid receptor
Molecular Pharmacology, Vol. 82, Núm. 2, pp. 178-188
-
Enhancement of μ-opioid receptor desensitization by nitric oxide in rat locus coeruleus neurons: Involvement of reactive oxygen species
Journal of Pharmacology and Experimental Therapeutics, Vol. 342, Núm. 2, pp. 552-560
-
Erratum: What does CNTNAP2 reveal about autism spectrum disorder?. [Trends in Molecular Medicine 18 (2012), 156-163].
Trends in Molecular Medicine
-
HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity
Nature Neuroscience, Vol. 15, Núm. 9, pp. 1245-1254
-
Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal
Biological Psychiatry, Vol. 71, Núm. 3, pp. 214-223
-
Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function
Journal of Biological Chemistry, Vol. 287, Núm. 53, pp. 44301-44319
-
Influence of δ-opioid receptors in the behavioral effects of nicotine
Neuropsychopharmacology, Vol. 37, Núm. 10, pp. 2332-2344
-
Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus
Neuropharmacology, Vol. 62, Núm. 5-6, pp. 1944-1953
-
Modulation of neurotransmitter release in orexin/hypocretin-2 receptor knockout mice: A microdialysis study
Journal of Neuroscience Research, Vol. 90, Núm. 3, pp. 588-596
-
Neurological soft signs in patients with psychosis and cannabis abuse: a systematic review and meta-analysis of paradox.
Current pharmaceutical design, Vol. 18, Núm. 32, pp. 5156-5164
-
Partially hydrolyzed guar gums reduce dietary fatty acid and sterol absorption in guinea pigs independent of viscosity
Lipids, Vol. 47, Núm. 7, pp. 697-705
-
Plasma antioxidant capacity is reduced in Asperger syndrome
Journal of Psychiatric Research, Vol. 46, Núm. 3, pp. 394-401